GHP Q4 2021

2 GHP / Q4 2021 Contents , Welcome to the 2021 Q4 edition of Global Health & Pharma Magazine, providing you with all the latest news and features from across the healthcare and pharmaceutical landscape. The last couple of years have witnessed a wide variety of businesses, across multiple industries, flourish and thrive even in the face of adversity. However, here we can see a selection of particularly innovative and focused businesses that have astonishingly excelled throughout the global pandemic. For instance, our cover company Smart Blood Analytics have introduced two fine products that have altered the way we diagnose illnesses. This experienced Swiss business harnesses the power of Artificial Intelligence to detect any current or future defects within the blood. This is an invaluable service that can ultimately conquer the late diagnosis of serious illness and disease. With developments like this we can look towards the future with confidence. Join us as we delve deeper into many other successful business stories that have not only stood the test of time, but that have grown exponentially throughout some of the darkest days. As usual, we hope you enjoy this issue and we look forward to seeing you again for Q1 2022. Sofi Bajor, Editor Website: AI Global Media, Ltd. (AI) takes reasonable measures to ensure the quality of the information on this web site. However, AI will not assume any legal liability or responsibility for the accuracy, correctness or completeness of any information that is available through this web site. If errors are brought to our attention, we will try to correct them. The information available through the website and our partner publications is for your general information and use and is not intended to address any particular finance or investment requirements. In particular, the information does not constitute any form of advice or recommendation by us or any of our partner publications and is not intended to be relied upon by users in making or refraining from making any investment or financial decisions. Appropriate independent advice should be obtained before making any such decision. Any arrangement made between you and any third party named in the site is at your sole risk and responsibility.